Literature DB >> 15336398

MexZ-mediated regulation of mexXY multidrug efflux pump expression in Pseudomonas aeruginosa by binding on the mexZ-mexX intergenic DNA.

Yasuhiro Matsuo1, Shima Eda, Nobuyuki Gotoh, Eisaku Yoshihara, Taiji Nakae.   

Abstract

MexZ is a transcriptional regulator of the mexXY multidrug transporter operon, which confers aminoglycoside resistance on Pseudomonas aeruginosa. Highly purified MexZ showed direct binding with a specific site of the mexZ-mexX intergenic DNA when probed by a gel retardation assay. Both in vitro chemical cross-linking experiments and an in vivo two-hybrid expression system showed that the active form of MexZ, which is capable of binding the intergenic DNA, appeared to be a dimer. These results explain the mechanism by which MexZ represses transcription of the mexXY operon, but do not explain the substrate-induced hyperproduction of MexXY. The presence of inducer antibiotic in the gel-retardation assay mixture failed to detect altered MexZ-probe DNA interaction suggesting the possible involvement of an additional regulator.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15336398     DOI: 10.1016/j.femsle.2004.07.010

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  45 in total

Review 1.  Modes and modulations of antibiotic resistance gene expression.

Authors:  Florence Depardieu; Isabelle Podglajen; Roland Leclercq; Ekkehard Collatz; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

2.  Antibiotic inducibility of the MexXY multidrug efflux system of Pseudomonas aeruginosa: involvement of the antibiotic-inducible PA5471 gene product.

Authors:  Yuji Morita; Mara L Sobel; Keith Poole
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

Review 3.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

4.  Synergy of drug combinations in treating multidrug-resistant Pseudomonas aeruginosa.

Authors:  Meher Rizvi; Junaid Ahmad; Fatima Khan; Indu Shukla; Abida Malik; Hiba Sami
Journal:  Australas Med J       Date:  2015-01-31

Review 5.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

6.  Characterization of BreR interaction with the bile response promoters breAB and breR in Vibrio cholerae.

Authors:  Francisca A Cerda-Maira; Gabriela Kovacikova; Brooke A Jude; Karen Skorupski; Ronald K Taylor
Journal:  J Bacteriol       Date:  2012-11-09       Impact factor: 3.490

Review 7.  Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance.

Authors:  Lucía Fernández; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.

Authors:  David R Cameron; Yue Shan; Eliza A Zalis; Vincent Isabella; Kim Lewis
Journal:  J Bacteriol       Date:  2018-08-10       Impact factor: 3.490

9.  Transcriptome Profiling of Antimicrobial Resistance in Pseudomonas aeruginosa.

Authors:  Ariane Khaledi; Monika Schniederjans; Sarah Pohl; Roman Rainer; Ulrich Bodenhofer; Boyang Xia; Frank Klawonn; Sebastian Bruchmann; Matthias Preusse; Denitsa Eckweiler; Andreas Dötsch; Susanne Häussler
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

Review 10.  Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance.

Authors:  David C Hooper; George A Jacoby
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.